Literature DB >> 19439849

Neurological complications of Chikungunya virus infection.

Nitin H Chandak1, Rajpal S Kashyap, Dinesh Kabra, Poornima Karandikar, Sonali S Saha, Shweta H Morey, Hemant J Purohit, Girdhar M Taori, Hatim F Daginawala.   

Abstract

BACKGROUND: In May 2006, there was a large Chikungunya virus infection (CHIKV) outbreak in the Nagpur district of Maharashtra, a province in western India. Usually, CHIKV is a self-limiting febrile illness. However, neurological complications have been described infrequently. AIM: To study the clinical characteristics of various neurological complications associated with CHIKV infections.
MATERIALS AND METHODS: Patients with neurological complications following CHIKV infection during the outbreak were the subjects of the study. On the basis of clinical features and investigative findings, patients were grouped into various neurological syndromes: Encephalitis, myelopathy, peripheral neuropathy, myeloneuropathy, and myopathy. Cerebrospinal fluid (CSF) samples were also collected for biochemical and serological studies.
RESULTS: Of the 300 patients with CHIKV infection seen during the study period, June-December 2006, 49 (16.3%) [M : F: 42:7] had neurological complications. The neurological complications included: Encephalitis (27, 55%), myelopathy (7, 14% ), peripheral neuropathy (7, 14%), myeloneuropathy (7, 14%), and myopathy (1, 2%). Reverse Transcriptase polymerase chain reaction (RT-PCR) and real-time PCR was positive in the CSF in 16% and 18%, respectively.
CONCLUSION: Recent CHIKV infection was associated with various neurological complications, suggesting neurotropic nature of the virus. The outcome of the neurological complications is likely to be good.

Entities:  

Mesh:

Year:  2009        PMID: 19439849     DOI: 10.4103/0028-3886.51289

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  70 in total

1.  Persistence of viral RNA in chikungunya virus-infected Aedes aegypti (Diptera: Culicidae) mosquitoes after prolonged storage at 28°C.

Authors:  Mangala Mavale; Anakkathil Sudeep; Mangesh Gokhale; Supriya Hundekar; Deepti Parashar; Youwaraj Ghodke; Vidya Arankalle; Akhilesh Chandra Mishra
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

2.  An Unusual Case of Myelitis with Myositis.

Authors:  Neera Choudhary; Prashant Makhija; Vinod Puri; Geeta Anjum Khwaja; Ashish Duggal
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Acquired auditory neuropathy spectrum disorder after an attack of chikungunya: case study.

Authors:  Prashanth Prabhu
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-03       Impact factor: 2.503

4.  Case reports of neuro-Chikungunya in southern Thailand.

Authors:  Sarunyou Chusri; Pisud Siripaitoon; Siriporn Hirunpat; Khachornsakdi Silpapojakul
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

5.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

6.  Third Cranial Nerve Palsy in the Setting of Chikungunya Virus Infection.

Authors:  Réda Benzekri; Rabih Hage; Harold Merle
Journal:  Am J Trop Med Hyg       Date:  2016-05-31       Impact factor: 2.345

7.  Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic.

Authors:  Alladi Mohan; D H N Kiran; I Chiranjeevi Manohar; D Prabath Kumar
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

8.  Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications.

Authors:  Rajpal S Kashyap; Shweta H Morey; Nitin H Chandak; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Cerebrospinal Fluid Res       Date:  2010-08-13

9.  An essential role of antibodies in the control of Chikungunya virus infection.

Authors:  Fok-Moon Lum; Teck-Hui Teo; Wendy W L Lee; Yiu-Wing Kam; Laurent Rénia; Lisa F P Ng
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

10.  Emergence and re-emergence of viral diseases of the central nervous system.

Authors:  Diane E Griffin
Journal:  Prog Neurobiol       Date:  2009-12-10       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.